IVD Raw Materials Market Research Report
PREBOOK THIS REPORT - SAVE 10%

IVD Raw Materials Market - Global Outlook & Forecast 2022-2027

TO BE PUBLISHED : May 2022 | Pages : 328

Up to $525 off Prebook this report

THE GLOBAL IVD RAW MATERIALS MARKET SIZE WAS VALUED AT USD 24.34 BILLION IN 2021 AND IS EXPECTED TO REACH USD 34.25 BILLION BY 2027, GROWINF AT A CAGR OF 5.86% DURING THE FORECAST PERIOD

The Global In Vitro Diagnostics (IVD) Raw Materials Market Size, Share, & Trends Analysis Report by

  • Product: Antibody & Antigen, Enzymes, Proteins, Biological Buffers, and Others
  • Technology: Clinical Chemistry, Immunochemistry, Molecular Diagnostics, and Others
  • End-User: Pharma & Biotech Companies, Diagnostic Laboratories, and Others
  • Geography: Europe, North America, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

328 Pages

icon-table

164 Tables

icon-chart

140 Charts

icon-region

5 Regions

icon-country

13 Countries

icon-company

39 Companies

icon-market

4 Market Segment

IVD RAW MATERIALS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 34.25 BILLION (2027)
CAGR (REVENUE) 5.86% (2022-2027)
BASE YEAR 2021
FORECAST PERIOD 2022-2027
MARKET SEGMENTS Product: Antibody & Antigen, Enzymes, Proteins, Biological Buffers, and Others, Technology: Clinical Chemistry, Immunochemistry, Molecular Diagnostics, and Others, End-User: Pharma & Biotech Companies, Diagnostic Laboratories, and Others, Geography: Europe, North America, APAC, Latin America, and Middle East & Africa
GEOGRAPHICAL ANALYSIS Europe, North America, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED Germany, Italy, France, UK, Spain, US, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa

MARKET OVERVIEW

IVD raw materials market size was valued at USD 24.34 billion in 2021 and is expected to reach USD 34.25 billion by 2027, growing at a CAGR of 5.86% during the forecast period.

With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share. It is expected to have the highest incremental growth of USD 3.92 billion and absolute growth of 44.41% during the forecast period.

The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased the speed and ease of using the devices the workforce is thoroughly trained and adopted. Furthermore, the global IVD raw materials market is expected to witness an incremental growth of USD 9.91 billion and absolute growth of 40.73% by 2027.

KEY HIGHLIGHTS

  • Growing trends for point of care diagnostics and personalized medicine contribute to the growth of the IVD raw materials market.
  • Investment in the development and commercial launch of IVD instruments and rapid test kits to diagnose several infectious diseases and their applications in the research segment will boost the market in developed countries.
  • In 2021, pharma & biotech companies accounted for the major share of 62.19% in the global IVD raw materials market. However, diagnostic laboratories are likely to witness the highest absolute growth of 43.37% during the forecast period.
  • Vendors offer a broad portfolio of quality enzymes that are highly suitable for manufacturing diagnostic kits and reagents. Manufacturers are also exploring new enzyme sources from enormous enzymes and optimizing and transforming the most appropriate enzyme molecules.

THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:

  • Product
  • Technology
  • End-User
  • Geography

SEGMENTATION ANALYSIS

Rapid tests developed through clinical chemistry provides test results immediately. Manufacturers offer many IVD raw materials applicable to clinical chemistry methods. The global IVD raw materials market by clinical chemistry is expected to reach USD 12.14 billion by 2027. Furthermore, private laboratories have expanded their footprints in recent years, especially in developing countries, which has stimulated market growth. Moreover, the demand for standalone reference laboratories is gradually rising due to the prevalence of epidemic and pandemic conditions across the globe. The global IVD raw materials market by diagnostic laboratories will grow at a CAGR of over 6% during 2022-2027.

COMPETITIVE LANDSCAPE

Major manufacturers of IVD raw materials are focusing on their proprietary processing techniques that satisfy the raw material requirements of the IVD industry and provide IVD raw materials made to their own with the off-the-shelf specification. Vendors are constantly investing resources in R&D projects based on market trends and the demand for general health management. Key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to enhance sales and profit margins. Strategic M&As continue to be an essential competitive strategy for key players to expand product offerings, access new technology, or increase market share. Vendors also focus on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the IVD raw materials market.

GEOGRAPHICAL ANALYSIS

In 2021, Europe dominated the global IVD raw materials market compared to other regions. This region is a mature market with developed diagnostic infrastructure available in most countries. The demand for advanced molecular diagnostics in the European countries has gone high owing to the presence of advanced infrastructure in healthcare diagnosis. Point of care diagnostics is the latest trend in the European market. The Europe IVD raw materials market is expected to reach USD 11.80 billion by 2027.

The report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

  • Segmentation Analysis by Product
    • Antibody & Antigen
    • Enzymes
    • Proteins
    • Biological Buffers
    • Others
  • Segmentation Analysis by Technology
    • Clinical Chemistry
    • Immunochemistry
    • Molecular Diagnostics
    • Others
  • Segmentation Analysis by End-User
    • Pharma & Biotech Companies
    • Diagnostic Laboratories
    • Others
  • Geography
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
    • North America
      • US
      • Canada
    • APAC
      • China
      • Japan
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • Turkey
      • Saudi Arabia
      • South Africa

Frequently Asked Questions

HOW BIG IS THE IVD RAW MATERIALS MARKET?

The IVD raw materials market to reach USD 34.25 billion by 2027.

WHAT ARE THE GROWTH ENABLERS IN THE IVD RAW MATERIALS MARKET?

Increasing prevalence of infectious & chronic diseases, growing awareness for early diagnosis and disease prevention, and surge in demand For IVD testing & devices are the growth enablers in the market.

WHO ARE THE KEY PLAYERS IN THE IVD RAW MATERIALS MARKET

Key players include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KGaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific.

WHICH REGION HOLDS THE LARGEST SHARE IN THE IVD RAW MATERIALS MARKET?

Europe holds the largest share in the IVD raw materials market.

WHAT ARE THE KEY TRENDS IN THE IVD RAW MATERIALS MARKET?

Rising demand for point of care PCR diagnostics, personalized medicine, and molecular diagnostics are the key trends in the IVD raw materials market.

Download Free Sample

The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027.

The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period:

  • Increasing Prevalence of Infectious & Chronic Diseases
  • Growing Awareness for Early Diagnosis and Disease Prevention
  • Surge In Demand for IVD Testing & Devices
  • Rise In Availability of Advanced Home Care Kits for Cancer Diagnostics

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the IVD raw materials market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

Key Vendors

  • Aalto Bio Reagents
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Fapon Biotech
  • Fujirebio
  • Merck KGaA
  • Hoffmann-La Roche
  • Thermo Fisher Scientific

Other Prominent Vendors

  • ABclonal
    • Business Overview
    • Product Offerings
  • BBI Solutions
  • Beijing Diagreat Biotechnology
  • Biofootprints Healthcare
  • BioPorto
  • Creative Diagnostics
  • CUSABIO Technology
  • EUPROTEIN
  • Eximio Biotec
  • GenScript ProBio
  • Getein Biotech
  • Glentham Life Sciences
  • HyTest 
  • ImmunoDiagnostics
  • LGC
  • Medix Biochemica
  • Meridian Bioscience
  • More Diagnostics
  • MP Biomedicals
  • Nanjing Okay Biotechnology
  • Nitto Boseki
  • OYC Europe
  • Prahas Healthcare
  • Promega
  • ReAgent
  • Rockland Immunochemicals
  • Sekisui Diagnostics
  • SERION Immunologics
  • Signalway Antibody
  • Suzhou Yacoo Science
  • Trina Bioreactives
  • Watson International
  • Wuhan Huamei Biotech

Please reach us at enquiry@arizton.com

Please reach us at enquiry@arizton.com

Select a license type that suits your business needs

single-user Single User Licence
$3375.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3825.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4725.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1350.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date